PARENTERAL DRUGS (INDIA) LTD.-$

Company Profile

PARENTERAL DRUGS (INDIA) LTD.-$ had its IPO on under the ticker symbol PARENTLD.

The company operates in the sector and industry. PARENTERAL DRUGS (INDIA) LTD.-$ has a staff strength of 0 employees.

Stock update

Shares of PARENTERAL DRUGS (INDIA) LTD.-$ opened at ₹3.08 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹3.08 - ₹3.39, and closed at ₹3.39.

This is a +4.63% increase from the previous day's closing price.

A total volume of 1,250 shares were traded at the close of the day’s session.

In the last one week, shares of PARENTERAL DRUGS (INDIA) LTD.-$ have slipped by -10.08%.

PARENTERAL DRUGS (INDIA) LTD.-$'s Key Ratios

PARENTERAL DRUGS (INDIA) LTD.-$ has a market cap of ₹0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months PARENTERAL DRUGS (INDIA) LTD.-$’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures PARENTERAL DRUGS (INDIA) LTD.-$'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, PARENTERAL DRUGS (INDIA) LTD.-$’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q3.6666666666667, PARENTERAL DRUGS (INDIA) LTD.-$’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

PARENTERAL DRUGS (INDIA) LTD.-$’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PARENTERAL DRUGS (INDIA) LTD.-$’s profitability.

PARENTERAL DRUGS (INDIA) LTD.-$ stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

PARENTERAL DRUGS (INDIA) LTD.-$ stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹0

Total Liabilities

₹0

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

PARENTERAL DRUGS (INDIA) LTD.-$ ended 1970 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.

PARENTERAL DRUGS (INDIA) LTD.-$ ended 1970 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

PARENTERAL DRUGS (INDIA) LTD.-$’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.

In 1970, PARENTERAL DRUGS (INDIA) LTD.-$'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, PARENTERAL DRUGS (INDIA) LTD.-$ paid ₹0 in dividends in 1970.

Other key metrics

Current Trading Price

₹3.39

52-Week High

₹5.4

52-Week Low

₹3.18

Analyst Target Price

₹

PARENTERAL DRUGS (INDIA) LTD.-$ stock is currently trading at ₹3.39 per share. It touched a 52-week high of ₹5.4 and a 52-week low of ₹5.4. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹4.31 and 200-day moving average was ₹3.77 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.